Sector
RealtyOpen
₹158.52Prev. Close
₹158.52Turnover(Lac.)
₹3,143.21Day's High
₹160Day's Low
₹153.6652 Week's High
₹16952 Week's Low
₹74.15Book Value
₹32.15Face Value
₹2Mkt Cap (₹ Cr.)
4,046.11P/E
40.62EPS
3.9Divi. Yield
1.52Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 51.36 | 51.36 | 51.36 | 51.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 757.4 | 777.63 | 962.49 | 775.46 |
Net Worth | 808.76 | 828.99 | 1,013.85 | 826.82 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 72.3 | 73.68 | 125.29 | 147.16 |
yoy growth (%) | -1.88 | -41.18 | -14.85 | 15.39 |
Raw materials | -9.38 | -31.43 | -47.95 | -42.15 |
As % of sales | 12.97 | 42.65 | 38.27 | 28.64 |
Employee costs | -22.59 | -20.78 | -20.74 | -22.83 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 16.51 | 93.68 | 44.17 | 32.44 |
Depreciation | -3.91 | -3.22 | -3.77 | -5.08 |
Tax paid | -3.15 | -0.13 | -2.39 | 0.85 |
Working capital | -37.75 | 55.84 | -10.43 | -55.94 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -1.88 | -41.18 | -14.85 | 15.39 |
Op profit growth | 188.45 | -66.5 | 65.31 | 9.72 |
EBIT growth | -82.13 | 111.89 | 36.02 | 13.73 |
Net profit growth | -85.71 | 123.92 | 51.98 | 11.19 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 157.49 | 127.24 | 78.22 | 73.52 | 73.93 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 157.49 | 127.24 | 78.22 | 73.52 | 73.93 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 54.77 | 64.26 | 89.18 | 10.27 | 93.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
DLF Ltd DLF | 826.75 | 189.59 | 2,04,609.27 | 3.79 | 0.6 | 405.32 | 117.41 |
Godrej Properties Ltd GODREJPROP | 2,873 | 85.47 | 79,855.18 | 491.32 | 0 | 189.47 | 378.06 |
Prestige Estates Projects Ltd PRESTIGE | 1,801.05 | 342.6 | 77,473.29 | 19.2 | 0.09 | 397.1 | 274.75 |
Oberoi Realty Ltd OBEROIRLTY | 1,742.6 | 39.44 | 63,323.15 | 459.28 | 0.23 | 1,173.97 | 357.84 |
Phoenix Mills Ltd PHOENIXLTD | 3,497.8 | 221.8 | 62,520.14 | 96 | 0.14 | 118.23 | 283.03 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Chirayu R Amin
Managing Director & CEO
Malika C Amin
Non Executive Director
Udit Amin
Non Executive Director
Abhijit Joshi
Independent Director
Sameer Khera
Company Sec. & Compli. Officer
Drigesh Mittal
Independent Director
Rati Desai
Independent Director
Mayank Amin
Independent Director
Girish Hirode
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Alembic Ltd
Summary
Alembic Ltd is one of the Indias most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara. The Company has been dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.The company is a ISO-9002 and ISO-14001 certified company with manufacturing practices and facilities that conform to WHO-GMP guidelines. They manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. They are having their manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.Alembic Ltd was incorporated in the year 1907 with the name Alembic Chemical Works Co Ltd in Vadodara to manufacture tinctures and alcohol. They Started to manufacture cough syrup, vitamins, tonics and sulphur durgs in the year 1940. In the year 1961, they inaugrated the Pencillin Palnt. In the year 1968, they started to manufacture Streptomycin.In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In Ju
Read More
The Alembic Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹157.57 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alembic Ltd is ₹4046.11 Cr. as of 09 Sep ‘24
The PE and PB ratios of Alembic Ltd is 40.62 and 5.03 as of 09 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Alembic Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Alembic Ltd is ₹74.15 and ₹169 as of 09 Sep ‘24
Alembic Ltd's CAGR for 5 Years at 31.68%, 3 Years at 11.26%, 1 Year at 90.19%, 6 Month at 72.49%, 3 Month at 56.26% and 1 Month at 9.37%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice